IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial. (nature.com)

Authors: Tiu C … Meier P Journal: Nature Communications Published: 2026-09-30 DOI: https://doi.org/10.1038/s41467-026-77552-7